편집
13,823
번
잔글
→ATOM2Chia A et al. 5y Clinical Trial on Atropine for the Treatment of Myopia 2 : Myopia Control w Atropine 0.01% Eyedrops. Ophthalmology. 2016 Feb;123(2):391-399. 연결 (2016)
| 41번째 줄: | 41번째 줄: | ||
|- | |- | ||
|rowspan=2|5년 | |rowspan=2|5년 | ||
|근시 진행||-1.98±1.10 (P<0.001)||-1.83±1.16 (P=0.003)||-1.38±0.98 | |근시 진행 (D)||-1.98±1.10 (P<0.001)||-1.83±1.16 (P=0.003)||-1.38±0.98 | ||
|- | |- | ||
||안축장 증가|| | ||안축장 증가 (mm)||0.87±0.49 (P=0.075)||0.85±0.53 (P=0.144)||0.75±0.48 | ||
|} | |} | ||
아트로핀 0.01%는 높은 농도와 비교하여 최소한의 산동 (0.8mm), 최소한의 조절 감소 (2~3D) 을 보였고, 근거리 시력 감소를 보이지 않았다. | |||
=== LAMP<ref>Yam JC et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study : A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05, 0.025, 0.01% Atropine Eye Drops in Myopia Control. ''Ophthalmology''. 2019 Jan;126(1):113-124. [https://pubmed.ncbi.nlm.nih.gov/30514630/연결]</ref> (2019, 홍콩) === | === LAMP<ref>Yam JC et al. Low-Concentration Atropine for Myopia Progression (LAMP) Study : A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05, 0.025, 0.01% Atropine Eye Drops in Myopia Control. ''Ophthalmology''. 2019 Jan;126(1):113-124. [https://pubmed.ncbi.nlm.nih.gov/30514630/연결]</ref> (2019, 홍콩) === | ||